|本期目录/Table of Contents|

[1]刘婧,龚冬火,刘洪娟,等.2型糖尿病患者血清S100A14水平与冠状动脉病变的相关性研究[J].国际心血管病杂志,2017,06:369-372，385.
　LIU Jing,GONG Donghuo,LIU Hongjuan,et al.Association of serum S100A14 with coronary artery disease in type 2 diabetic patients[J].International Journal of Cardiovascular Disease,2017,06:369-372，385.
点击复制

2型糖尿病患者血清S100A14水平与冠状动脉病变的相关性研究(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2017年06期
页码:
369-372，385
栏目:
临床研究
出版日期:
2017-11-25

文章信息/Info

Title:
Association of serum S100A14 with coronary artery disease in type 2 diabetic patients
作者:
刘婧; 龚冬火; 刘洪娟; 郭君君; 陈桂芳; 郑宏超
200444 上海大学生命科学学院(刘婧,陈桂芳); 200025 上海交通大学医学院附属瑞金医院(龚冬火,刘洪娟); 200031 中国科学院上海生命科学研究院(郭君君); 200031 上海市徐汇区中心医院心内科(郑宏超)
Author(s):
LIU Jing1;  GONG Donghuo2;  LIU Hongjuan2;  GUO Junjun3;  CHEN Guifang1;  ZHENG Hongchao4
1. School of Life Sciences of Shanghai University, Shanghai 200444; 2. Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025; 3. Shanghai Institutes for Biological Sciences, Shanghai 200031; 4. Department of Cardiology, Xuhui
关键词:
S100A14蛋白;  2型糖尿病;  动脉粥样硬化;  冠状动脉粥样硬化性心脏病
Keywords:
S100 calcium binding protein A14;  Type 2 diabetes mellitus;  Atherosclerosis;  Coronary atherosclerotic heart disease
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2017.06.013
文献标识码:
A
摘要:
目的:探讨血清S100A14水平与2型糖尿病患者冠状动脉(冠脉)粥样硬化病变发生的相关性。方法:入选行冠脉造影检查的2型糖尿病合并冠心病患者240例(糖尿病合并冠脉病变组)和单纯2型糖尿病患者80例(单纯糖尿病组),应用ELISA法测定患者血清S100A14水平,以冠脉病变血管支数评估冠脉病变严重程度。结果:糖尿病合并冠脉病变组血清S100A14水平显著高于单纯糖尿病组[(1 566.76±443.10)pg/mL对(959.53±140.02)pg/mL,P<0.
Abstract:
Objective:To investigate whether serum S100A14 level is related to the presence and severity of coronary artery disease(CAD)in patients with type 2 diabetes mellitus(T2DM).Methods:We enrolled 240 patients with T2DM and CAD(DM with CAD group)and 80 patient

参考文献/References

[1] 富江,时博,刘赫. 糖尿病伴冠状动脉粥样硬化性心脏病及其临床对策[J]. 实用糖尿病杂志, 2015, 9(6):4-6.
[2] Zimmer DB, Cornwall EH, Landar A, et al. The S100 protein family: history, function, and expression[J]. Brain Res Bull, 1995, 37(4):417-429.
[3] Heizmann CW, Fritz G, Sch?fer BW. S100 proteins: structure, functions and pathology[J]. Front Biosci, 2002, 7(5):d1356-d1368.
[4] Tanaka M, Ichikawa-Tomikawa N, Shishito N, et al. Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion[J]. BMC Cancer, 2015, 15(1):53.
[5] Pietas A, Schlüns K, Marenholz I, et al. Molecular cloning and characterization of the human S100A14 gene encoding a novel member of the S100 family[J]. Genomics, 2002, 79(4):513-522.
[6] Wang HY, Zhang JY, Cui JT, et al. Expression status of S100A14 and S100A4 correlates with metastatic potential and clinical outcome in colorectal cancer after surgery[J]. Oncol Rep, 2010, 23(1):45-52.
[7] Jin Q, Chen H, Luo A, et al. S100A14 stimulates cell proliferation and induces cell apoptosis at different concentrations via receptor for advanced glycation end products(RAGE)[J]. PLoS One, 2011, 6(4):e19375.
[8] Ehmsen S, Hansen LT, Bak M, et al. S100A14 is a novel independent prognostic biomarker in the triple-negative breast cancer subtype[J]. Int J Cancer, 2015, 137(9):2093-2103.
[9] Donato R. Intracellular and extracellular roles of S100 proteins[J]. Microsc Res Tech, 2003, 60(6):540-551.
[10] Hansson GK, Hermansson A. The immune system in atherosclerosis[J]. Nat Immunol, 2011, 12(3):204-212.
[11] 郭君君,刘婧,张素洁,等. 磷酸二酯酶-9A对评估冠状动脉粥样硬化病变程度的临床价值[J]. 国际心血管病杂志, 2017, 44(3):181-184.
[12] Schmidt BM, Arora R. Primary prevention of cardiovascular complications in type Ⅱ diabetes patients using aspirin: a complicated tale[J]. Am J Ther, 2013, 20(3):275-278.
[13] 戴道鹏,沈迎,张瑞岩,等. 血清可溶性髓样细胞触发受体-1水平对冠状动脉粥样斑块进展的预测价值[J]. 国际心血管病杂志, 2016, 43(5):303-306.
[14] Davies PF, Civelek M, Fang Y, et al. Endothelial heterogeneity associated with regional athero-susceptibility and adaptation to disturbed blood flow in vivo[J]. Semin Thromb Hemost, 2010, 36(3):265-275.
[15] Nakashima Y, Wight TN, Sueishi K. Early atherosclerosis in humans: role of diffuse intimal thickening and extracellular matrix proteoglycans[J]. Cardiovasc Res, 2008, 79(1):14-23.
[16] Merrilees MJ, Beaumont BW, Braun KR, et al. Neointima formed by arterial smooth muscle cells expressing versican variant V3 is resistant to lipid and macrophage accumulation[J]. Arterioscler Thromb Vasc Biol, 2011, 31(6):1309-1316.
[17] Tavora F, Kutys R, Li L, et al. Adventitial lymphocytic inflammation in human coronary arteries with intimal atherosclerosis[J]. Cardiovasc Pathol, 2010, 19(3):e61-e68.
[18] Wang TJ. Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction[J]. Circulation, 2011, 123(5):551-565.
[19] 何云云,刘春蕾,何昆仑,等. S100蛋白与心血管疾病[J]. 中华老年心脑血管病杂志, 2014, 16(12):1326-1328.
[20] Jaiswal JK, Lauritzen SP, Scheffer L, et al. S100A11 is required for efficient plasma membrane repair and survival of invasive cancer cells[J]. Nat Commun, 2014, 5:3795.

备注/Memo

备注/Memo:
基金项目:新一轮上海医学重点专科建设计划(ZK2012A39)
通信作者:郑宏超,Email:zhenghchao@126.com
更新日期/Last Update: 2017-12-10